Testosterone Therapy Is Changing: What the Latest HHS and FDA Updates Mean for Men's Health

For years, testosterone replacement therapy has been surrounded by questions, concerns, and restrictions. Now, federal health officials are taking another look at the science, and the conversation surrounding men's hormone health is evolving.

If you've ever felt like your energy isn't what it used to be, noticed changes in your sex drive, or struggled with symptoms that make you wonder whether your hormones are playing a role, you're certainly not alone.

Testosterone is an essential hormone involved in sexual health, muscle maintenance, bone density, red blood cell production, and many other functions throughout the male body.

Yet testosterone replacement therapy (TRT) has been the subject of considerable debate, particularly when it comes to cardiovascular health, prostate cancer, and age-related testosterone decline.

In June 2026, the U.S. Department of Health and Human Services (HHS) announced that the Food and Drug Administration (FDA) was requesting important updates to testosterone therapy product labeling.

For patients and healthcare providers, these developments represent an opportunity to revisit what we know about testosterone therapy and how it may fit into individualized men's healthcare.

At Restore Pharma, we believe patients deserve access to current information, thoughtful medical guidance, and personalized treatment options.

What's Changing with Testosterone Replacement Therapy in 2026?

On June 18, 2026, HHS announced that the FDA was requesting revisions to testosterone product labeling following a review of newer clinical evidence.

Three areas received particular attention.

1. Reconsidering restrictions related to age-associated low testosterone

Historically, testosterone products have included limitations concerning men whose testosterone levels decline with age without a clearly established underlying medical condition.

The FDA is now requesting removal of the labeling statement that safety and effectiveness have not been established in men with age-related hypogonadism.

This is an important shift in how regulators are interpreting the available evidence. It does not mean testosterone is appropriate for every aging man, but it opens the door to a more informed discussion about treatment eligibility.

2. Updating prostate cancer warnings

For years, testosterone therapy has carried significant warnings regarding prostate cancer.

Following its review, the FDA reported that available clinical and epidemiological evidence has generally not demonstrated an increased incidence of prostate cancer among men receiving testosterone therapy.

The agency requested that the formal contraindication be narrowed to metastatic prostate cancer.

However, long-term uncertainties remain, and prostate health evaluation and monitoring continue to be important parts of testosterone therapy.

3. Reexamining concerns about enlarged prostate

Benign prostatic hyperplasia (BPH), commonly called an enlarged prostate, affects many men as they age.

Historically, testosterone therapy labels have warned that treatment could worsen urinary symptoms associated with BPH.

The FDA's review found that clinical trial data have not demonstrated worsening symptoms in men with mild to moderate BPH, although evidence remains limited for men with severe symptoms.

These requested changes reflect an evolving understanding of testosterone therapy, not the elimination of its risks.

What About Testosterone and Heart Health?

One of the biggest questions surrounding testosterone therapy has been whether it increases the risk of heart attack or stroke.

The TRAVERSE trial, published in 2023, provided important information.

Researchers studied more than 5,200 men with symptoms of low testosterone, documented low testosterone levels, and existing cardiovascular disease or cardiovascular risk factors.

Participants received either testosterone gel or a placebo.

The results showed major adverse cardiovascular events in 7.0% of men receiving testosterone compared with 7.3% receiving placebo.

These findings supported the conclusion that testosterone therapy was not associated with an increased risk of major cardiovascular events compared with placebo in the studied population over the trial's follow-up period.

This was a meaningful development in testosterone research.

However, the study also identified higher rates of certain adverse events, including atrial fibrillation, pulmonary embolism, and acute kidney injury, among testosterone-treated participants.

Testosterone products can also increase blood pressure, which remains an important safety consideration.

The takeaway is not that testosterone therapy is risk-free. It's that clinicians now have better evidence to help evaluate benefits and risks for appropriate patients.

Could Low Testosterone Be Affecting Your Quality of Life?

Testosterone levels naturally change throughout adulthood, but not every decline requires medical treatment.

For some men, clinically low testosterone can contribute to symptoms such as reduced sexual desire, erectile difficulties, decreased muscle mass, lower bone density, and reduced energy.

These symptoms can also have other causes, including poor sleep, stress, certain medications, thyroid disorders, and other medical conditions.

That's why testosterone replacement therapy should begin with a proper evaluation, not simply a desire to reach a higher number on a laboratory report.

Healthcare providers typically assess symptoms alongside repeated morning testosterone measurements and other appropriate laboratory tests.

For men with confirmed testosterone deficiency, treatment may improve certain symptoms, particularly sexual function. Benefits vary, and testosterone is not a proven solution for every concern involving fatigue, mood, or physical performance.

The goal should always be to identify what's actually contributing to how you feel and determine whether hormone therapy makes sense for you.

Why Personalized Testosterone Therapy Matters

No two patients are exactly alike.

One patient may prefer a topical formulation, while another may require a different delivery method. Some patients have sensitivities to inactive ingredients, while others need a dosage strength that is not commercially available.

This is where compounding pharmacy can play a valuable role.

At Restore Pharma, we specialize in personalized medication formulations and work closely with healthcare providers to help meet individual patient needs.

Our testosterone compounding capabilities include customized topical preparations when clinically appropriate and prescribed by a licensed healthcare provider.

Compounded testosterone is not FDA-approved and should not automatically be considered safer or more effective than commercially available testosterone products. However, compounding can offer an individualized option when an FDA-approved medication cannot meet a patient's specific medical needs.

We believe the pharmacy should be an active participant in patient care, not simply the final stop after a prescription is written.

A Pharmacy Partner for Testosterone and Hormone Replacement Therapy

For healthcare providers, prescribing hormone therapy involves more than selecting a medication.

It requires attention to formulation, dosing, patient education, follow-up, and communication.

At Restore Pharma, our pharmacists work directly with prescribers to discuss individualized hormone formulations and patient-specific needs.

We offer a boutique pharmacy experience with accessible pharmacists, responsive communication, convenient prescription submission, complimentary shipping to eligible locations, and a typical 24–48-hour turnaround for many compounded prescriptions.

Whether you're a primary care provider, urologist, men's health specialist, or hormone therapy clinic, our goal is to make working with a compounding pharmacy straightforward and dependable.

As new clinical evidence and regulatory guidance emerge, we believe strong collaboration between pharmacists and prescribers becomes even more valuable.

The Future of Men's Hormone Health Is About Better Information

The latest HHS and FDA developments are an important reminder that medicine continues to evolve.

Recommendations change as researchers gather better evidence, and patients benefit when healthcare professionals remain informed.

Testosterone therapy is not appropriate for everyone, and decisions still require careful consideration of medical history, fertility goals, cardiovascular health, prostate health, and ongoing monitoring.

But for men with genuine testosterone deficiency, a thoughtful conversation with a qualified healthcare provider can be an important step toward improving their health and quality of life.

At Restore Pharma, we're excited to be part of that conversation.

Looking for testosterone replacement therapy compounding in Tampa Bay?

Whether you're a patient exploring your hormone health or a prescriber looking for a pharmacy partner, Restore Pharma is here to help you navigate personalized treatment options.

Connect with our pharmacists to learn more about our testosterone compounding services and how we support individualized hormone replacement therapy.

Restore Pharma — Feel Your Best. Then Feel Better.

Sources and publication notes

The article draws on the following sources:

Next
Next

FDA Peptide Regulations Explained: What a PCAC Vote Really Means for Patients, Prescribers, and Compounding Pharmacies